ECO Animal Health Group (EAHGF) Stock Price, News & Analysis

Company Overview

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. The company was founded in 1972 and is headquartered in New Malden, the United Kingdom.

Key Stats

• Today's Range: $2.00 to $2.00
• 50-Day Range: $2.00 to $2.00
• 52-Week Range: $2.00 to $2.00
• Volume: N/A
• Average Volume: 2,550 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EAHGF Stock Analysis - Frequently Asked Questions

How have EAHGF shares performed this year?

ECO Animal Health Group's stock was trading at $2.00 at the beginning of 2025. Since then, EAHGF stock has increased by 0.0% and is now trading at $2.00.
View the best growth stocks for 2025 here.

How do I buy shares of ECO Animal Health Group?

Shares of EAHGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceuticals - Major
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EAHGF
• CUSIP: N/A
• CIK: N/A
• Web: ecoanimalhealthgroupplc.com
• Phone: 44.208.336.2900
• Fax: N/A
• Employees: 207
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A